The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkin's lymphoma patients.

Advances in clinical pathology : the official journal of Adriatic Society of Pathology

Volumn 6, Issue 1, 2002, Pages 11-16

  Damiani, Daniela ^a   Grimaz, Stefania ^a   Sperotto, Alessandra ^a   Geromin, Antonella ^a   Skert, Cristina ^a   Cerno, Michela ^a   Rinaldi, Cristina ^a   Fanin, Renato ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; F MACHOP PROTOCOL; F-MACHOP PROTOCOL; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; LEUKAPHERESIS; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NONHODGKIN LYMPHOMA; PATHOLOGY; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; CYTARABINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEMALE; FLUOROURACIL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; VINCRISTINE;

EID: 34447537798     PISSN: 11255552     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)